BioPharmSignal logoBioPharmSignal

Biotech News

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Stereotaxis (STXS)StereotaxisCompany update

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has established the first robotic center for the treatment of cardiac arrhythmias in Latvia and has successfully treated initial patients with the Genesis Robotic Magnetic Navigation System.

Related news

STXSStereotaxis2026-10-30 12:03 EST

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

STXSStereotaxis2026-11-02 13:48 EST

First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT

TMCITreace Medical Concepts2026-11-06 12:04 EST

Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System

ICCMIceCure Medical2026-10-27 12:33 EST

IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation

JNJJohnson & Johnson2026-10-25 14:24 EST

Subcutaneous RYBREVANT®▼ (amivantamab) demonstrates 77% overall response rate in first-line treatment of patients with certain types of advanced head and neck cancer

JNJJohnson & Johnson2026-10-23 11:09 EST

European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapse

PLSEPulse Biosciences2026-10-07 11:00 EST

Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment

SGHTSight Sciences2026-10-01 11:05 EST

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

ANGOAngioDynamics2026-09-28 20:30 EST

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

EHCEncompass Health Corporation2026-09-24 20:30 EST

Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital

View all latest news

Stereotaxis

Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC...

Recent company news

STXSStereotaxis2026-11-02 13:48 EST

First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT

STXSStereotaxis2026-10-30 12:03 EST

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

STXSStereotaxis2026-10-22 12:04 EST

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

STXSStereotaxis2026-10-20 11:40 EST

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

STXSStereotaxis2026-09-16 11:59 EST

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Stock data

Close
1.05 USD
Market cap
192.54M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States